Category Reports | ResearchPool

Almost there...

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

First Name*

Last Name*

Country*

Email*

Password* ( 6 or more alphabetic and numerical characters )

Get financial insights straight to your inbox.

YES

I have read and accept ResearchPool Terms & Conditions, and Privacy Policy, including our Cookie Use Policy

Already on ResearchPool? Login Now

Back to the main directory

Press Release

Hepsor AS consolidated unaudited interim report for Q2 2025 and six months by GlobeNewsWire
H1 2025: Outstanding delivery of Nexans’ model, 2025 guidance upgraded by GlobeNewsWire
IMCD reports EBITA of EUR 275 million in the first half of 2025 by GlobeNewsWire
WORLDLINE : renouvelle son équipe dirigeante by GlobeNewsWire
Résultats du 1er semestre 2025 by GlobeNewsWire
WORLDLINE : Résultats S1 2025 - Communiqué by GlobeNewsWire
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma by GlobeNewsWire
Nexans announces the departure of its Deputy Chief Executive Officer and Chief Financial Officer. The Company has initiated the search for a new Chief Financial Officer by GlobeNewsWire
Solvay second quarter 2025 results by GlobeNewsWire
Resultaten Solvay van het tweede kwartaal 2025 by GlobeNewsWire
Melexis Q2 2025 résultats by GlobeNewsWire
JDE Peet’s reports half-year results 2025 by GlobeNewsWire
SEC-COM wird neuer Vertriebspartner von Ascom in Deutschland by GlobeNewsWire
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France by GlobeNewsWire
„Novaturas“ pristatys pirmojo 2025 m. pusmečio finansinius rezultatus (neaudituotus) by GlobeNewsWire
Exosens delivers strong H1 2025 performance in a highly-dynamic Defense market; Fully on track to 2025 guidance by GlobeNewsWire
Sanoma Corporation, Half-Year Report 1 January–30 June 2025: Increased operational EBIT driven by Learning by GlobeNewsWire
Aedifica NV/SA: 2025 half year financial report by GlobeNewsWire
Danone: A strong first half; Consistently delivering quality results by GlobeNewsWire
AB Science a reçu l’approbation règlementaire de pays européens pour initier la troisième étape de la phase I/II visant à combiner sa molécule AB8939 avec le venetoclax dans le traitement de la LMA by GlobeNewsWire
Avis financier 30 06 205 by GlobeNewsWire
„Ignitis grupė“ rugpjūčio 13 d. pristatys 2025 m. 6 mėn. rezultatus by GlobeNewsWire
Transaction in Own Shares by GlobeNewsWire
Hermès International: 2025 Half-year Results by GlobeNewsWire
Transaction in own shares by GlobeNewsWire

Hepsor AS 2025 II kvartali ja kuue kuu konsolideeritud auditeerimata vahearuanne by GlobeNewsWire
S1 2025 : Excellente exécution du modèle de Nexans, perspectives 2025 revues à la hausse by GlobeNewsWire
Worldline : announces a renewed management team to transform the company by GlobeNewsWire
H1 2025 results by GlobeNewsWire
Worldline : H1 2025 results press release by GlobeNewsWire
Vopak reports strong HY1 2025 results driven by a resilient portfolio and is increasing FY 2025 outlook by GlobeNewsWire
Communiqué de presse: Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation médicament orphelin pour le myélome multiple aux États-Unis by GlobeNewsWire
Nexans annonce le départ de son Directeur Général Adjoint et Directeur Financier, et lance la recherche d’un successeur pour le poste de Directeur Financier by GlobeNewsWire
Solvay : résultats du deuxième trimestre 2025 by GlobeNewsWire
Melexis Q2 2025 results by GlobeNewsWire
Melexis Q2 2025 resultaten by GlobeNewsWire
Fiverr Announces Second Quarter 2025 Results by GlobeNewsWire
Ascom has signed up SEC-COM to become a new distribution partner in Germany by GlobeNewsWire
Novaturas will present unaudited financial results for the first half of 2025 by GlobeNewsWire
Bourse Direct : Résultats consolidés du 1er semestre 2025, Hausse de 16,1% du volume d’ordres exécutés et des revenus de courtage, Croissance du recrutement de nouveaux comptes, Produit net bancaire consolidé de 34,3 millions d’euros by GlobeNewsWire
Exosens enregistre une forte performance au S1 2025, dans un marché de la Défense très dynamique ; Résultats parfaitement en ligne avec les objectifs 2025 by GlobeNewsWire
Sanoma Oyj, Puolivuosikatsaus 1.1.-30.6.2025: Operatiivinen liikevoitto parani Learningin vetämänä by GlobeNewsWire
DANONE : Résultats très solides au 1er semestre ; Poursuite d’une performance de qualité trimestre après trimestre by GlobeNewsWire
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML by GlobeNewsWire
Transactions under share buy-back programme by GlobeNewsWire
Ignitis Group to present 6M 2025 results on 13 August by GlobeNewsWire
Ignitis Group to present 6M 2025 results on 13 August by GlobeNewsWire
Hermès International: 2025 Half-year Financial Report by GlobeNewsWire
Hermès International : Résultats du 1er semestre 2025 by GlobeNewsWire
Hermès International : Rapport financier semestriel 2025 by GlobeNewsWire

«
1
2
...
18243
18244
18245
18246
18247
18248
18249
...
18253
18254
»

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Press Release

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe